Literature DB >> 11159516

Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development.

C K Qu1, S Nguyen, J Chen, G S Feng.   

Abstract

Shp-1 and Shp-2 are cytoplasmic phosphotyrosine phosphatases with similar structures. Mice deficient in Shp-2 die at midgestation with defects in mesodermal patterning, and a hypomorphic mutation at the Shp-1 locus results in the moth-eaten viable (me(v)) phenotype. Previously, a critical role of Shp-2 in mediating erythroid/myeloid cell development was demonstrated. By using the RAG-2-deficient blastocyst complementation, the role of Shp-2 in lymphopoiesis has been determined. Chimeric mice generated by injecting Shp-2(-/-) embryonic stem cells into Rag-2-deficient blastocysts had no detectable mature T and B cells, serum immunoglobulin M, or even Thy-1(+) and B220(+) precursor lymphocytes. Collectively, these results suggest a positive role of Shp-2 in the development of all blood cell lineages, in contrast to the negative effect of Shp-1 in this process. To determine whether Shp-1 and Shp-2 interact in hematopoiesis, Shp-2(-/-):me(v)/me(v) double-mutant embryos were generated and the hematopoietic cell development in the yolk sacs was examined. More hematopoietic stem/progenitor cells were detected in Shp-2(-/-):me(v)/me(v) embryos than in Shp-2(-/-) littermates. The partial rescue by Shp-1 deficiency of the defective hematopoiesis caused by the Shp-2 mutation suggests that Shp-1 and Shp-2 have antagonistic effects in hematopoiesis, possibly through a bidirectional modulation of the same signaling pathway(s).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159516     DOI: 10.1182/blood.v97.4.911

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

Review 1.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

2.  Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality.

Authors:  Yuehai Ke; Eric E Zhang; Kazuki Hagihara; Dongmei Wu; Yuhong Pang; Rüdiger Klein; Tom Curran; Barbara Ranscht; Gen-Sheng Feng
Journal:  Mol Cell Biol       Date:  2007-07-23       Impact factor: 4.272

3.  SHP-2 tyrosine phosphatase in human diseases.

Authors:  Hong Zheng; Shawn Alter; Cheng-Kui Qu
Journal:  Int J Clin Exp Med       Date:  2009-01-30

Review 4.  Protein tyrosine phosphatases in the JAK/STAT pathway.

Authors:  Dan Xu; Cheng-Kui Qu
Journal:  Front Biosci       Date:  2008-05-01

5.  A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.

Authors:  Liang Li; Hardik Modi; Tinisha McDonald; John Rossi; Jiing-Kuan Yee; Ravi Bhatia
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

6.  Abnormal hematopoiesis in Gab2 mutant mice.

Authors:  Yi Zhang; Ernesto Diaz-Flores; Geqiang Li; Zhengqi Wang; Zizhen Kang; Eleonora Haviernikova; Sara Rowe; Cheng-Kui Qu; William Tse; Kevin M Shannon; Kevin D Bunting
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

7.  PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.

Authors:  Rebecca J Chan; Gen-Sheng Feng
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

Review 8.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation.

Authors:  Claudia Patrignani; David T Lafont; Valeria Muzio; Béatrice Gréco; Rob Hooft van Huijsduijnen; Paola F Zaratin
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

10.  Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).

Authors:  Helen Wheadon; Christine Edmead; Melanie J Welham
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.